LDL stands for low-density lipoprotein, a type of cholesterol found in the body. LDL is often referred to as bad cholesterol. This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes. High levels of good cholesterol, called high-density lipoprotein (HDL), may decrease risk of developing heart disease. HDL helps transport LDL cholesterol to liver to be broken down and thus helps avoid damage to heart. Doctor may order an LDL test as part of a routine exam to determine patient’s risk for heart disease and decide if any treatment is necessary.
Blood tests commonly report LDL-C: the amount of cholesterol which is estimated to be contained with LDL particles, on average, using a formula, the Friedewald equation. In clinical context, mathematically calculated estimates of LDL-C are commonly used as an estimate of how much low density lipoproteins are driving progression of atherosclerosis.

Market Analysis and Insights: Global LDL Test Market
The global LDL Test market size is projected to reach US$ 9315.7 million by 2027, from US$ 6307.4 million in 2020, at a CAGR of 5.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global LDL Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global LDL Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global LDL Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global LDL Test market.

Global LDL Test Scope and Market Size
LDL Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global LDL Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
LDL-C
LDL-P
LDL-B
Others

Segment by Application
Hospital
Clinic
Biotechnological Company
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sekisui Diagnostics
XpressBio
Randox Laboratories
Reckon Diagnostics
DiaSys Diagnostics
Roche
Medtronic
Lifespan Biosciences
MyBioSource
CUSABIO Technology